Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...
The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...
A team of biomolecular engineers, pathologists, and internal medicine specialists at the University of Texas Medical Branch, ...
A significant percentage of patients with Lyme arthritis and other Lyme disease manifestations were positive for anti-RA33 antibodies.
C1q antibodies in IgG4-related disease are common and associated with renal involvement and cutaneous small-vessel vasculitis ...
Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...
News Medical on MSN2d
Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic developmentGyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers, today announced the introduction of its Gyrolab® HEK293 HCP Type SN Kit ...
News Medical on MSN11d
Sphere Fluidics launches Cyto-Mine Chroma and announces Early Access ProgramSphere Fluidics, a leading provider of innovative picodroplet-based microfluidics solutions for functional single cell ...
PEMGARDA™ (pemivibart) net product revenue of $13.8 million, 48% growth over Q3 2024 net product revenue of $9.3 ...
LOUIS, MISSOURI / ACCESSWIRE / 6, 2025 / Leinco Technologies, a leader in antibody and protein development, is thrilled to announce that it has been awarded a $1M grant from the Gates Foundation. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback